Skip to main content

Hydroxychloroquine Sulfate Tablets Shortage

Last Updated: May 26, 2016
Status: Resolved

Products Affected - Description
    • Hydroxychloroquine sulfate tablet, Ranbaxy, 200 mg, 100 count, NDC 63304-0296-01
    • Hydroxychloroquine sulfate tablet, Ranbaxy, 200 mg, 500 count, NDC 63304-0296-05
Reason for the Shortage
    • Concordia acquired Plaquenil tablets from Covis in April 2015.
    • Ranbaxy has hydroxychloroquine on shortage due to a regulatory issue.
    • Sandoz states the hydroxychloroquine shortage was due to increased demand.
    • Zydus has hydroxychloroquine tablets available to current customers.
    • West-Ward discontinued hydroxychloroquine tablets in September 2014.
Available Products
    • Plaquenil tablet, Concordia, 200 mg, 100 count, NDC 24987-0562-10
    • Hydroxychloroquine sulfate tablet, Mylan, 200 mg, 100 count, NDC 00378-0373-01
    • Hydroxychloroquine sulfate tablet, Sandoz, 200 mg, 100 count, NDC 00781-1407-97
    • Hydroxychloroquine sulfate tablet, Sandoz, 200 mg, 500 count, NDC 00781-1407-52
    • Hydroxychloroquine sulfate tablet, Zydus, 200 mg, 100 count, NDC 68382-0096-01

Estimated Resupply Dates

    • Ranbaxy has product on long-term back order and the company cannot estimate a release date.
    • All other suppliers have product available.

Updated

Updated May 26, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 5, 2014 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer